3 Biotech Stocks To Avoid
After a history of failures, these three biotech stocks are running out of ideas and cash to keep their operations going.
Celsion(CLSN)
Nasdaq Capital Market (Nasdaq)
CLSN
$1.71
-$0.14
-7.6%
Price as of March 5, 2021, 9:00 p.m. EST
View Interactive CLSN Charts
A biotechnology company dedicated to furthering the development and commercialization of treatment systems for cancer and other diseases using focused heat energy in combination with other therapeutic devices or heat-activated genes.
Interactive Chart
News & Analysis: Celsion
A Fool Looks Back
A lot of things happened this past week. Let's check it out.
The Fool Looks Ahead
It will be an interesting week if you know where to look.
This Week in Biotech
A look back at the biggest stories this week in biotech and what they mean for investors.
3 Horrendous Health-Care Stocks This Week
The Fool looks at 3 horrendous health-care stocks from the past week.
Why Celsion Shares Were Eviscerated
Is this meaningful or just another movement?
Why Shares of Celsion Got Crushed Today
What caused shares of this drugmaker to spiral today?
Celsion Collapses on Failure: What's Next?
HEAT trial failed. Shares down over 80%. Is there any hope?
This Week in Biotech: Part 1
A look back at the biggest stories this week in biotech and what they mean for investors.
New Hope for Celsion Investors?
This agreement adds more suspense as investors await Phase 3 clinical trial results from Celsion.
